BDBM303350 2-amino-8-fluoro-N- [[6-(4-pyridylmethyl)- 2-pyridyl] methyl]quinazoline- 4-carboxamide::US10138212, Example 112
SMILES: Nc1nc(C(=O)NCc2cccc(Cc3ccncc3)n2)c2cccc(F)c2n1
InChI Key: InChIKey=BGEZILNDGFFCAU-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenosine receptor A2a (Homo sapiens (Human)) | BDBM303350 (2-amino-8-fluoro-N- [[6-(4-pyridylmethyl)- 2-pyrid...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description Binding affinities of compounds of the invention for the human A2a receptor were determined in a competition binding assay using Scintillation Proxim... | US Patent US10138212 (2018) BindingDB Entry DOI: 10.7270/Q2WM1GGB | |||||||||||
More data for this Ligand-Target Pair |